• IRLAB Therapeutics set total issued shares at 146,461,921 as of July 31, 2026, matching total voting rights.
• Share count comprised 146,382,145 series A shares, 79,776 series B shares; each share carries one vote.
• Change followed completion of a rights issue, including an overallotment issue, completed during July.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRLAB Therapeutics AB published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.